XML 70 R56.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Stockholders' Equity - Narrative (Details) - USD ($)
shares in Millions, $ in Millions
3 Months Ended
Mar. 31, 2024
Dec. 31, 2023
Milestone Payments | Verily Life Sciences | Collaborative Arrangement    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Issuance of common stock in connection with achievement of regulatory approval milestone, net of issuance costs (in shares) 1.5 3.7
Restricted Stock Units (RSUs) and Performance Shares | Equity Incentive Plan 2015    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Unrecognized estimated compensation costs $ 362.5  
Unrecognized compensation costs recognized weighted average period (in years) 2 years 2 months 12 days